Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Astepro 0.15% vs Nasonex in Perennial Allergic Rhinitis
NCT00720382Phase 3Completed
- Sponsor
- Meda
- Start
- Mar 2007
- Primary completion
- Jun 2008
- Countries
- 1
01
Overview
A Phase 3 trial of azelastine in perennial allergic rhinitis (PAR), sponsored by Meda. Started Mar 2007; status: completed.
02
Drugs
azelastine
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT00720382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00720382.